Progyny, Inc. (PGNY)
Fuera de horario:
Progyny, Inc.
1359 Broadway
New York, NY 10018
United States
212 888 3124
https://www.progyny.com
Sector(es): Healthcare
Industria: Health Information Services
Empleados a tiempo completo: 563
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. David J. Schlanger | Executive Chairman | 513.57k | 46.8M | 1959 |
| Mr. Peter Anevski | CEO & Director | 1.09M | 21.17M | 1967 |
| Mr. Michael Sturmer | President | 836.49k | N/D | 1977 |
| Mr. Mark S. Livingston | Chief Financial Officer | 749.56k | 1.36M | 1966 |
| Ms. Allison Swartz | Executive VP, General Counsel & Secretary | 546.22k | N/D | 1990 |
| Mr. Steven Leist | Chief Technology Officer | N/D | N/D | N/D |
| Mr. James Hart | Vice President of Investor Relations | N/D | N/D | N/D |
| Ms. Risa Fisher | Chief Marketing Officer | N/D | N/D | N/D |
| Ms. Cassandra Pratt | Chief Human Resources Officer | N/D | N/D | N/D |
| Ms. Julie Stadlbauer | Chief Business Development Officer | N/D | N/D | N/D |
Descripción
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Gestión corporativa
La calificación ISS Governance QuickScore de Progyny, Inc. a partir del 1 de mayo de 2024 es 9. Las puntuaciones principales son Auditoría: 2; Junta: 8; Derechos del accionista: 7; Compensación: 10.
